Search Login Register
Channelopathies
Summary
309
relevant articles (4 outcomes,
15 trials/studies)
found for this Disease
Description:
A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.
Also Known As:
Channelopathy
Key Drugs and Agents for Channelopathies
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Calcium
:
1 outcome 3 studies in 48 results
: IBA
-
Calcium Channels (Calcium Channel)
:
1 outcome 3 studies in 17 results
: IBA
-
Potassium
:
1 outcome in 40 results
: IBA
-
Carbamazepine (Tegretol)
:
1 outcome in 2 results
:
FDA 23
Generic
-
Anticonvulsants (Antiepileptic Drugs)
:
1 outcome in 2 results
: IBA
-
Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)
:
1 outcome in 1 result
: IBA
-
Carbonic Anhydrase Inhibitors
:
1 outcome in 1 result
: IBA
-
Ion Channels (Ion Channel)
:
5 studies in 102 results
: IBA
-
Sodium Channels (Sodium Channel)
:
2 studies in 22 results
: IBA
-
Sodium
:
1 study in 53 results
: IBA
Show All >>
Diseases Related to Channelopathies
-
Epilepsy (Aura)
-
Ataxia (Dyssynergia)
-
Temporal Lobe Epilepsy
-
Anorexia Nervosa
-
Paralysis (Palsy)
Show All >>
Key Therapies for Channelopathies
Efficacy Chart >>
-
Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
:
5 results
-
Drug Therapy (Chemotherapy)
:
3 results
-
Plasma Exchange
:
1 result
-
Pancreatectomy
:
1 result
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.